WhatsApp
Facebook
Instagram
X (Twitter)
YouTube
LinkedIn

24/7 Customer Support

ibrance palbociclib capsules 100mg 21capsules per bottle

Description

 Indication & Scope

Palbociclib Capsules (Ibrance®) is selective CDK4/6 inhibitor. It blocks cyclin-dependent kinase 4 and 6, arrests tumor cell cycle at G1 phase, inhibits proliferation of HR+/HER2- breast cancer cells, and synergizes with endocrine agents.

  • Mechanism
    Inhibit CDK4/6, block tumor cell cycle progression, suppress HR+/HER2- breast cancer proliferation
  • Drug class
    Oral CDK4/6 targeted anti-tumor capsule
  • Clinical use
    HR positive, HER2 negative advanced breast cancer combined with endocrine therapy
Specification
Generic Name Palbociclib Capsules
Brand Name Ibrance®
Ingredient Palbociclib
Dosage Form Hard Gelatin Capsules
Package 100mg*21 capsules/bottle
Conditions Treated Hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer, combined with endocrine therapy
Taboos Hypersensitivity to palbociclib or excipients, pregnancy, lactation
Place of origin Germany
Priscription Type Prescription drug (Rx)
Storage Conditions Store below 25°C, sealed and moisture-proof
Manufacturer Pfizer Manufacturing Deutschland GmbH,Betriebsstatte Freiburg
Registration Authority National Medical Products Administration (NMPA)
Approval number HJ20180040
Approval Date  July 01, 2025
Shelf Life 36 months

How to use ?

Recommended Dose: Standard dose: 125mg once daily orally for 21 consecutive days, followed by 7 days off treatment to form a 28-day cycle, take with food;Dose reduction: Step down to 100mg qd, then 75mg qd; discontinue permanently if intolerance remains

 

Time: Repeat cycles continuously until disease progression or unmanageable toxicity

 

Interaction: Avoid strong CYP3A4 inhibitors/inducers; monitor neutropenia regularly

 

Side effects: Neutropenia, leukopenia, fatigue, anemia, alopecia, nausea, stomatitis; major severe risk: severe neutropenia

Important Notice

This product shall only be used for post-exposure rabies prophylaxis by professional medical staff. It must be applied combined with rabies vaccine and injected via wound infiltration plus intramuscular routes as specified. Do not administer intravenously or alter the dosage at will. Hypersensitivity monitoring is required throughout the whole injection process.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References
2.NMPA
3.FDA
4.EMA

FAQ

What molecular targets does palbociclib inhibit?

CDK4 and CDK6.

Should I take palbociclib with food?

Yes, take together with meals.

What therapy is palbociclib combined with clinically?

Endocrine therapy.

What subtype of breast cancer is it indicated for?

HR positive, HER2 negative advanced breast cancer.

Ibrance® | Palbociclib Capsules | Breast Cancer | DengYueRX

INN: Palbociclib
Indications: Breast Cancer
Dosage Form: Hard Gelatin Capsules
Strength: 100mg/Capsule

Original price was: $636.04.Current price is: $540.63.

Low MOQ

WHO-GMP

Worldwide Delivery

Compliance and Regulatory Documents

Related Products

Scroll to Top

Your Cart

Your Cart

Your Cart is Empty

Start Shopping
Continue Shopping
Payment Details
Sub Total $0.00